客自订检测开发市场报告：2031 年趋势、预测与竞争分析

全球自订检测开发市场前景广阔，在医疗、生物、环境和学术市场都存在机会。预计全球自订检测开发市场从 2025 年到 2031 年的复合年增长率为 7.7%。该市场的主要驱动力是对个人化医疗和标靶治疗日益增长的需求，以及正在进行的生物标记发现和检验。

• Lucintel 预测，在预测期内，检测开发将经历按类型分類的最高成长率。
• 从应用角度来看，医疗保健预计将实现最高成长。
• 根据地区，预计北美将在预测期内实现最高成长。

客自订检测开发市场的策略性成长机会

客自订分析开发市场中的广泛应用提供了多种策略成长机会，这主要归功于技术进步和新兴市场不断变化的医疗需求。

• 基因组学和蛋白​​质组学检测：各种研究和临床领域对自订基因组学和蛋白​​质组学检测的需求日益增长。能够分析复杂生物样本的检测方法的开发将提高我们对疾病机制的理解并促进个人化治疗。
• 感染疾病诊断：高感染疾病负担需要开发快速诊断测试和自订检测系统。关注感染疾病诊断有利于许多卫生系统的公共卫生和个别患者。
• 药物成果：对个人化医疗的重视正在推动伴随诊断的潜在成长。这些专门的检测有助于确定患者对特定治疗的反应，有助于制定更好的治疗计划并提高治疗效果。
• 环境检测：自订检测市场正随着环境测试的趋势而多样化，其中经皮和血液检测用于检测毒素和病原体。透过此类检测解决污染问题有助于促进公众健康和遵守卫生法规。
• PoC 侦测：对各种即时诊断 (PoC) 解决方案的需求日益增长，推动了对客自订PoC 侦测的需求。提供简单、经济高效的照护现场替代方案可以减少患者在及时接受检测时的不适感，并提高医疗服务的品质。

这些成长机会代表着自订检测服务市场的显着扩张。利用这些应用程式将使相关人员能够推动创新并增强各个领域的诊断能力。

自订检测开发市场驱动因素与挑战

客自订检测开发市场受到多种动态因素的影响，包括技术、经济和监管，这些因素为相关人员带来了机会和挑战。

推动客自订检测开发市场的因素有：

• 技术发展：不断推出新产品，尤其是具有工业自动化和多路復用的检测技术，对市场成长做出了重大贡献。这些进步将提高检测的有效性并改善其诊断和研究用途。
• 对标靶治疗系统的需求不断增加：向以患者为中心的医疗保健的转变正在支持对特定自订检测服务的需求。这项发展将实现更好、更有针对性的治疗方法，改善患者的治疗效果并促进市场成长。
• 增加研发支出：增加研发投资，特别是在生物技术和医疗保健领域的投资，正在推动自订检测市场的发展。这样的资助可以促进创造力并鼓励创造更好、更快的检测方法。
• 支持性政策：扩大监管规定使得自订侦测的核准流程变得更加容易。鼓励研究和诊断相关人员实施概念，促进新诊断方法快速进入市场。
• 全球健康倡议：改善全球健康的努力正在推动对准确、及时诊断的需求。客自订检测是一个不断成长的市场，因为它们在改善公共卫生方面发挥关键作用。

客製自订检测开发市场面临的挑战包括：

• 开发成本高：开发客製自订检测方法的成本可能很高，尤其是对于中小型公司而言。此类经济壁垒可能会限制新技术的好处，并限制一些公司进入市场。
• 复杂的监管环境：检测开发过程通常因监管要求而变得复杂。一些地区的法规严格而复杂，可能会延长产品上市的时间。
• 市场竞争：客自订检测服务市场高度分散，各公司都在争取市场占有率。这种竞争推高了成本，需要尖端研究来保持竞争力。

摘要：自订检测开发市场正受到这些市场驱动因素和挑战的共同驱动和影响。对于相关人员来说，制定策略来利用机会并减少障碍以在这种竞争环境中前进至关重要。

目录

第一章执行摘要

第二章全球自订检测开发市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球自订检测开发市场趋势（2019-2024）及预测（2025-2031）
• 全球自订检测开发市场（按类型）
  • 检测方法开发
  • 检测最佳化
  • 测定转化
  • 新分析物的开发
  • 自订联轴器
  • 自订使用
  • 样品测试
  • 其他的
• 全球自订检测开发市场（按应用）
  • 医疗保健
  • 生物学
  • 环境
  • 学术的
  • 其他的

第四章区域市场趋势与预测分析（2019-2031）

• 全球自订检测开发市场（按地区）
• 北美客自订检测开发市场
• 欧洲自订检测开发市场
• 亚太地区自订检测开发市场
• 世界其他地区自订检测开发市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球自订检测开发市场成长机会（按类型）
  • 全球客自订检测开发市场的成长机会（按应用）
  • 全球自订检测开发市场各区域成长机会
• 全球自订检测开发市场的新趋势
• 战略分析
  • 新产品开发
  • 全球客自订检测开发市场的产能扩张
  • 全球自订检测开发市场的企业合併
  • 认证和许可

第七章主要企业简介

• 2BScientific
• PerkinElmer
• Eurofins Discovery
• Thermos Fisher Scientific
• Creative Biolabs
• PlexBio
• Gyros Protein Technologies
• Mission Bio
• Sygnature Discovery
• AssayGate

The future of the global custom assay development market looks promising, with opportunities in the medicine, biology, environment, and academic markets. The global custom assay development market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine and targeted therapies and ongoing advancement in biomarker discovery and validation.

• Lucintel forecasts that, within the type category, assay development is expected to witness the highest growth over the forecast period.
• Within the application category, medicine is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Custom Assay Development Market

The custom assay development market is expanding while undergoing many changes due to the emergence of several trends. These trends reveal the market positioning and potential areas for development.

• Personalized Medicines Offer New Opportunities for Diagnostic Companies: The growth of personalized medicine is increasing the need for custom assays tailored to individual patient profiles. This situation attracts more complex diagnostics and therapies, which benefits patients and contributes to the overall progress of healthcare interventions.
• Addition of Artificial Intelligence and Automation: The use of artificial intelligence and simultaneous automation in the development of assays is increasing effectiveness and accuracy. These technologies optimize the design phase, minimize errors, and expedite the development of complex assays for new diagnostics.
• Growth of Multiplex Assays: Multiplex assays are transforming the market by enabling the simultaneous detection of several targets, thereby increasing the scope of diagnostics. This trend improves testing efficiency and conserves resources, which is advantageous in both clinical and research settings.
• Initiatives to Streamline Approvals for Custom Assays: More countries are adopting new regulations that simplify the approval process for custom assays, making standards more comprehensible for developers. This encouragement fosters new ideas and financial support for developing new assays, aiding market growth.
• Rising Significance of Point-of-Care Testing: The increasing demand for diagnostic procedures in doctors' offices or laboratories is driving advancements in custom assays. Innovations allow for timely diagnostics, enhancing the dynamics of change in a medically oriented healthcare system and promoting decentralization.

Such trends are being integrated into the custom assay development market to foster innovation, enhance efficiency, and, most importantly, provide personalized healthcare solutions.

Recent Developments in the Custom Assay Development Market

There have also been substantive developments in the custom assay development market stemming from technological advancements and strategic initiatives to improve testing accuracy and applicability.

• Advanced Multiplexing Technologies: Advanced multiplexing technologies enable the use of the same assay for the simultaneous measurement of various biomarkers. This marks a significant step towards improving research, clinical diagnostics, and decision-making, particularly in patient management.
• AI-Driven Assay Design: The assay design process is undergoing a revolution, largely due to the role of artificial intelligence. Understanding and simulating optimal assay conditions are part of AI algorithms that facilitate a more efficient test development process, allowing for quick dispensing of necessary test results in the medical field.
• Collaboration Initiatives: Partnerships and collaborations between biotech companies and research institutions are on the rise, helping to drive innovation in the study and development of assays. Such collaborations enhance resource sharing and aid in developing advanced assays that bring research closer to practical application.
• Growth in Emerging Countries: The development of custom assay services is rapidly expanding in less developed regions, especially in Asia. Local players are providing relevant and affordable products, increasing the market for diagnostics.
• Regulatory Improvements: New structured guidelines are opening doors for easier approval of custom assays. This development attracts relevant stakeholders to the field, promoting the creation of new strategies for assays.

These developments are changing the landscape of custom assay development by improving the quality and efficiency of testing solutions, ultimately leading to better healthcare systems.

Strategic Growth Opportunities for Custom Assay Development Market

A wide array of applications in the custom assay development market presents several strategic growth opportunities, primarily due to technological advancements and evolving healthcare demands.

• Assays for Genomics and Proteomics: There is a growing need for custom-made genomic and proteomic assays across various research and clinical areas. Creating assays that can profile complex biological samples will enhance the understanding of disease mechanisms and facilitate personalized therapies.
• Diagnosing Infectious Diseases: The high burden of infectious diseases necessitates the development of rapid diagnostic testing and custom-assayed systems. Focusing on infectious disease diagnostics benefits public health and individual patients in many healthcare systems.
• Pharmaceutical Outcomes: The emphasis on personalized medicine is driving growth potential for companion diagnostics. These specialized assays help determine how a patient will respond to specific therapies, aiding in better planning and effectiveness of treatments.
• Environmental Assays: The custom assay market is diversifying with the trend of environmental testing, where dermal and blood assays are used to detect toxins and pathogens. Addressing pollution through these assays promotes public health and compliance with health legislation.
• Point-of-Care Assays: The demand for point-of-care custom assays is rising due to the increasing need for extensive point-of-care solutions. Providing simple and cost-effective point-of-care alternatives will reduce patients' discomfort in accessing timely tests and improve healthcare service quality.

These growth opportunities indicate that the custom assay services market will expand significantly. By leveraging these applications, stakeholders can foster innovation and enhance diagnostics across various fields.

Custom Assay Development Market Driver and Challenges

The custom assay development market is influenced by several dynamic factors, including technological, economic, and regulatory aspects, which present both opportunities and challenges for stakeholders.

The factors driving the custom assay development market include:

• Technology Development: The continuous introduction of new products, especially assay technologies featuring industrial automation and multiplexing, has significantly contributed to market growth. These advancements enhance assay effectiveness and improve the quality of diagnostics and research utilization.
• Increase in Demand for Targeted Therapeutic Systems: The shift toward patient-centered care sustains the demand for specific custom assay services. This development enables better and more targeted treatment approaches, resulting in improved patient outcomes and market growth.
• Expansion of R&D Spending: Increased investment in research and development, particularly in biotechnology and healthcare, is boosting the custom assay market. This funding fosters creativity and the creation of better and faster assays.
• Supporting Policies: Widening regulatory provisions are making the approval process for custom assays increasingly straightforward. Stakeholders in research and diagnostics are encouraged to implement their concepts, facilitating quicker market entry for new diagnostics.
• Global Health Initiatives: Efforts to improve global health are increasing the demand for accurate and timely diagnostics. Custom assays play a crucial role in enhancing public health, thus expanding the market scope.

Challenges in the custom assay development market include:

• Unaffordable Development Costs: Developing custom assays can be particularly expensive for small and medium enterprises. These financial barriers may limit the advantages of new technologies and restrict market entry for some companies.
• Complex Regulatory Landscape: The process of developing assays can be cumbersome due to regulatory requirements. Stringent and convoluted rules in some regions can lengthen the time to market for products.
• Market Competition: The custom assay service market is highly fragmented, with various players competing for market share. This competition drives costs and necessitates up-to-date research to maintain a competitive edge.

In summary, the custom assay development market is driven and shaped by a combination of these drivers and challenges. It is crucial for stakeholders to devise strategies that capitalize on opportunities and minimize obstacles to advance in this competitive landscape.

List of Custom Assay Development Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, custom assay development companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the custom assay development companies profiled in this report include-

• 2BScientific
• PerkinElmer
• Eurofins Discovery
• Thermos Fisher Scientific
• Creative Biolabs
• PlexBio
• Gyros Protein Technologies
• Mission Bio
• Sygnature Discovery
• AssayGate

Custom Assay Development by Segment

The study includes a forecast for the global custom assay development market by type, application, and region.

Custom Assay Development Market by Type [Analysis by Value from 2019 to 2031]:

• Assay Development
• Assay Optimization
• Assay Conversion
• New Analyte Development
• Custom Coupling
• Custom Conjugation
• Sample Testing
• Others

Custom Assay Development Market by Application [Analysis by Value from 2019 to 2031]:

• Medicine
• Biology
• Environment
• Academic
• Others

Custom Assay Development Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Custom Assay Development Market

The market for developing specialized tests is constantly witnessing innovations, driven by technological advancements and an increasing need for customized diagnostic tools. The improvements in assay technology and a growing focus on personalized medicine are enabling the execution of better and more accurate tests in the healthcare and pharmaceutical industries. Here is a summary of recent developments in the United States, Chinese, German, Indian, and Japanese markets.

• United States: The custom assay market is experiencing significant expansion due to advances in multiplex assays and the rise of rapid testing methods. Firms are strategically positioning themselves in the personalized medicine segment, leading to a growing number of requests for assay development. Collaborative research between biotech companies and universities is enhancing research capabilities and accelerating development.
• China: There is increasing demand for custom assay development services in China, particularly in the fields of genomics and proteomics. Government investments in the health industry and biotechnology are fostering innovative development. Additionally, local companies are increasingly internationalizing the market by offering competitive rates and tailored solutions.
• Germany: Germany is a leading country in Europe, capturing a substantial market share in custom assay services. High-throughput screening technologies are becoming more prevalent in assay development processes. The incorporation of automation and artificial intelligence in biostatistics and biotechnologies is enabling researchers to enhance the sophistication of assay design for drug discovery and diagnosis.
• India: While a formal custom assay market is still emerging, India is currently experiencing a trend toward this sector due to rising demand for affordable diagnostic solutions. Advances in new technologies have empowered startups to produce cost-effective assays, particularly for infectious diseases. Collaborations with research organizations are further driving innovation in assay development.
• Japan: Japan is making significant strides in the technological advancement of custom assay activities. Increasing partnerships between industry and academic/community institutions are facilitating the introduction of more advanced and specific assays, essential for precision medicine and targeted therapy approaches.

Features of the Global Custom Assay Development Market

Market Size Estimates: Custom assay development market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Custom assay development market size by type, application, and region in terms of value ($B).

Regional Analysis: Custom assay development market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the custom assay development market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the custom assay development market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the custom assay development market by type (assay development, assay optimization, assay conversion, new analyte development, custom coupling, custom conjugation, sample testing, and others), application (medicine, biology, environment, academic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Custom Assay Development Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Custom Assay Development Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Custom Assay Development Market by Type
  • 3.3.1: Assay Development
  • 3.3.2: Assay Optimization
  • 3.3.3: Assay Conversion
  • 3.3.4: New Analyte Development
  • 3.3.5: Custom Coupling
  • 3.3.6: Custom Conjugation
  • 3.3.7: Sample Testing
  • 3.3.8: Others
• 3.4: Global Custom Assay Development Market by Application
  • 3.4.1: Medicine
  • 3.4.2: Biology
  • 3.4.3: Environment
  • 3.4.4: Academic
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Custom Assay Development Market by Region
• 4.2: North American Custom Assay Development Market
  • 4.2.1: North American Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.2.2: North American Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.3: European Custom Assay Development Market
  • 4.3.1: European Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.3.2: European Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.4: APAC Custom Assay Development Market
  • 4.4.1: APAC Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.4.2: APAC Market by Application: Medicine, Biology, Environment, Academic, and Others
• 4.5: ROW Custom Assay Development Market
  • 4.5.1: ROW Market by Type: Assay Development, Assay Optimization, Assay Conversion, New Analyte Development, Custom Coupling, Custom Conjugation, Sample Testing, and Others
  • 4.5.2: ROW Market by Application: Medicine, Biology, Environment, Academic, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Custom Assay Development Market by Type
  • 6.1.2: Growth Opportunities for the Global Custom Assay Development Market by Application
  • 6.1.3: Growth Opportunities for the Global Custom Assay Development Market by Region
• 6.2: Emerging Trends in the Global Custom Assay Development Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Custom Assay Development Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Custom Assay Development Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: 2BScientific
• 7.2: PerkinElmer
• 7.3: Eurofins Discovery
• 7.4: Thermos Fisher Scientific
• 7.5: Creative Biolabs
• 7.6: PlexBio
• 7.7: Gyros Protein Technologies
• 7.8: Mission Bio
• 7.9: Sygnature Discovery
• 7.10: AssayGate